Macroview Investment Management LLC Novo Cure LTD Transaction History

Macroview Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$15.61 - $23.34 $2,185 - $3,267	140 Added 35.09%	539 $8,000
Q2 2024 Jul 23, 2024	BUY	$11.83 - $24.05 $4,720 - $9,595	399 New	399 $6,000
Q2 2020 Aug 11, 2020	SELL	$57.2 - $74.41 $2,288 - $2,976	-40 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$57.05 - $95.75 $2,282 - $3,830	40 New	40 $3,000

290

75.6M

1.77M

538K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.03B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Macroview Investment Management LLC with notifications on news.